Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

NCT04949256

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope ( Site 0102) Duarte, California, United States
  • MedStar Washington Hospital Center ( Site 0186) Washington D.C., District of Columbia, United States
  • James Graham Brown Cancer Center ( Site 0117) Louisville, Kentucky, United States
  • Norton Cancer Institute ( Site 0116) Louisville, Kentucky, United States
View all 198 locations
View Trial Details
Completed

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

NCT06307093

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +22 more
Locations
  • State Budgetary Healthcare Institution of the city of Moscow "Moscow City Oncological Hospital No. 62 of the Department of Health of the City of Moscow" Istra, Moscow Oblast, Russia
  • "New Clinic" LLC Pyatigorsk, Stavropol Territory, Russia
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary" Barnaul, The Altai Republic, Russia
  • Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic Cheboksary, The Chuvash Republic, Russia
View all 23 locations
View Trial Details
Completed

A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

NCT07435324

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • State Budgetary Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Oncological Dispensary" Arkhangelsk, Russia
  • State Budgetary Healthcare Institution "Regional Oncological Dispensary" Irkutsk, Russia
  • State Budgetary Healthcare Institution of Moscow "Moscow City Oncological Hospital No. 62, Department of Health of Moscow" Istra, Russia
  • Regional Budgetary Healthcare Institution "Ivanovo Regional Oncological Dispensary" Ivanovo, Russia
View all 34 locations
View Trial Details
Completed

A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

NCT07435311

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary" Barnaul, Russia
  • Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic Cheboksary, Russia
  • State Budgetary Healthcare Institution "Regional Oncological Dispensary" Irkutsk, Russia
  • State Budgetary Healthcare Institution of Moscow "Moscow City Oncological Hospital No. 62, Department of Health of Moscow" Istra, Russia
View all 18 locations
View Trial Details
Completed

A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer

NCT05249426

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • CTR Georges-François Leclerc Dijon, France
  • CTR Leon Berard Lyon, France
  • HOP Timone Marseille, France
View all 25 locations
View Trial Details
Completed

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

NCT04609566

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
View all 90 locations
View Trial Details
Completed

Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer

NCT01772706

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +12 more
Locations
  • Institut de Cancerologie de l'Ouest Paul Papin Angers, France
  • Centre Guillaume le Conquérant Le Havre, France
  • Hôpital La Pitié Salpêtrière Paris, France
  • Centre hospitalier universitaire La Milétrie Poitiers, France
View Trial Details

Related conditions